Dr. Swayampakula Ramakanth

H.C. Wainwright & Co.

Recent Articles about Innate Pharma SA

Biopharma Shares Multiple 2025 Catalysts 01/17/2025

Innate Pharma SA's (IPHA:NASDAQ; IPH:Paris) long-term corporate strategy led to it recieving a Buy rating from H.C. Wainwright & Co.